NCT02313766

Brief Summary

Adults patients scheduled for elective surgery were randomly allocated to receive preoxygenation with spontaneous breathing, positive pressure ventilation (positive inspiratory pressure: 12 cmH2O) without PEEP, and with PEEP (positive inspiratory pressure: 12 cmH2O, PEEP: 6 cmH2O). Preoxygenation time was measured from face mask positioning to FEO2=90% (FEO2 : expired fraction of O2). After endotracheal tube placement the time until SpO2=93% (SpO2 : peripheral oxygen saturation) was measured during monitored apnoea. Patient's discomfort was recorded (visual analogue scale).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2006

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2007

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
6.9 years until next milestone

First Submitted

Initial submission to the registry

December 1, 2014

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 10, 2014

Completed
28 days until next milestone

Results Posted

Study results publicly available

January 7, 2015

Completed
Last Updated

April 14, 2016

Status Verified

March 1, 2016

Enrollment Period

1 year

First QC Date

December 1, 2014

Results QC Date

December 23, 2014

Last Update Submit

March 17, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time for Preoxygenationfrom Face Mask Positioning to FEO2=90%

    Time measured form face mask positioning until FEO2 reached 90% on the gas monitor

    up to 5 min

Secondary Outcomes (2)

  • Time Until SpO2=93%

    up to 10 min

  • Discomfort of the Preoxygenation Phase Self Reported by the Patient

    Before PACU leaving

Study Arms (3)

spontaneous breathing (SB)

NO INTERVENTION

preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%

positive pressure ventilation (PPV)

EXPERIMENTAL

PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90%

Other: PPV : positive pressure ventilation

PPV + PEEP

EXPERIMENTAL

PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90%

Other: PEEP : PPV + PEEP

Interventions

Inspiratory pressure support ventilation (12 cmH2O) without PEEP

positive pressure ventilation (PPV)

Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)

PPV + PEEP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I and II
  • Scheduled surgery with general anaesthesia and oro-tracheal intubation

You may not qualify if:

  • rapid sequence induction
  • anticipated difficult mask ventilation
  • anticipated difficult intubation
  • refusal to participate to the study and to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Hanouz JL, Lammens S, Tasle M, Lesage A, Gerard JL, Plaud B. Preoxygenation by spontaneous breathing or noninvasive positive pressure ventilation with and without positive end-expiratory pressure: A randomised controlled trial. Eur J Anaesthesiol. 2015 Dec;32(12):881-7. doi: 10.1097/EJA.0000000000000297.

MeSH Terms

Interventions

Intermittent Positive-Pressure VentilationPositive-Pressure Respiration

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Results Point of Contact

Title
Pr Jean-Luc Hanouz
Organization
CaenUH

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2014

First Posted

December 10, 2014

Study Start

October 1, 2006

Primary Completion

October 1, 2007

Study Completion

January 1, 2008

Last Updated

April 14, 2016

Results First Posted

January 7, 2015

Record last verified: 2016-03